Endothelial Progenitor Cells
Hierarchy of EPCs is based on clonogenic and proliferative potential
Published in Blood Weekly, January 20th, 2005
According to published research from the United States, "Emerging evidence to support the use of endothelial progenitor cells (EPCs) for angiogenic therapies or as biomarkers to assess cardiovascular disease risk and progression is compelling. However, there is no uniform definition of an EPC, which makes interpretation of these studies difficult. Although hallmarks of stem and progenitor cells are their ability to proliferate and to give rise to functional progeny, EPCs are primarily defined by the expression of cell-surface antigens."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-01-20)
More Articles from Blood Weekly
- Embryonic Stem Cell Research
Genes identified that are enriched in embryonic stem cells - Neural Stem Cell Transplantation
Neural SCT promotes long-term functional recovery after traumatic brain injury - Protein Signaling
Transcriptional activity of Smad proteins in development monitored in vivo - Tissue Engineering
Cartilage-like tissue engineered with mesenchymal SCs and silk protein scaffolds - Wound Healing
BM-derived cells contribute to epithelial engraftment during wound healing - Antiretroviral Therapy
Drug-dependent HIV-1 variant emerges during T20 fusion inhibitor therapy - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
